Neuberger Berman Group
GOSS icon

Neuberger Berman Group’s Gossamer Bio GOSS Stock Holding History

Neuberger Berman Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.44K Sell
14,795
-2,356
-14% -$658 ﹤0.01% 2338
2026
Q1 		$5.64K Buy
17,151
+4,593
+37% +$7.22K ﹤0.01% 2157
2025
Q4 		$38.9K Buy
+12,558
New +$35.8K ﹤0.01% 2065
2023
Q3 		– Sell
-12,446
Closed -$14.9K – 1837
2023
Q2 		$14.9K Buy
+12,446
New +$15.5K ﹤0.01% 1784

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Neuberger Berman Group's GOSS Position: Q2 2026 in Review

Neuberger Berman Group reduced its Gossamer Bio (GOSS) stake by 14% in Q2 2026, selling an estimated $658 and leaving 14,795 shares worth $2.44K. The position accounts for ﹤0.01% of the portfolio, ranked #2338.

Neuberger Berman Group first reported a position in GOSS in Q2 2023 and has held it in 4 quarters since. The position peaked at $38.9K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Neuberger Berman Group held 14,795 shares of Gossamer Bio worth $2.44K as of Q2 2026.
  • Neuberger Berman Group sold 2,356 Gossamer Bio shares in Q2 2026, an estimated $658.
  • Gossamer Bio made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #2338 holding.
  • Neuberger Berman Group first reported a position in Gossamer Bio in Q2 2023 and has held it in 4 quarters since.
  • Neuberger Berman Group's Gossamer Bio position peaked at $38.9K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.